UPDATE : Thursday, May 23, 2019
상단여백
SNUH professor develops candidate substance for subarachnoid hemorrhage by Lee Han-soo 2019-05-23 17:22
Optimal radiotherapy condition found for breast reconstructive surgery patients by Lee Han-soo 2019-05-23 16:13
Asan Medical Center ranks 1st among local hospitals: Newsweek by Lee Han-soo 2019-05-23 15:01
OliX confident of its age-related macular degeneration treatment’s efficacy by Lee Han-soo 2019-05-23 13:48
Prosecutors seek arrest warrant of Samsung BioLogics CEO by Lee Han-soo 2019-05-23 11:19
라인
Sillajen, CHA Hospital to co-develop immunotherapy by Lee Han-soo 2019-05-22 18:26
SK Bioscience's shingles vaccine increases market share by Lee Han-soo 2019-05-22 17:04
Handok, Sanofi to promote vaccines jointly by Lee Han-soo 2019-05-22 15:48
‘Dupixent is sole systemic, long-term treatment for atopic dermatitis’ by Lee Han-soo 2019-05-22 14:44
CMC researchers discover new strategy in treating liver cancer by Lee Han-soo 2019-05-21 17:13
라인
Ministry grants additional indication to MSD’s immunotherapeutic drug by Lee Han-soo 2019-05-21 14:55
[Pre-ASCO 2019] ABL Bio: ABL001- bispecific antibody with indications for anti-cancer therapy by Lee Han-soo 2019-05-21 12:47
Researchers identify novel protein enzymes that repair mutant DNA by Lee Han-soo 2019-05-21 12:00
Roche’s breast cancer drug gains more insurance benefits by Lee Han-soo 2019-05-21 10:44
Bridge Biotherapeutics releases first-in-human study for idiopathic pulmonary fibrosis treatment by Lee Han-soo 2019-05-20 15:29
라인
'Yuyu should – and will -- be reborn as new drug developer' by Lee Han-soo 2019-05-17 17:11
[Pre-ASCO 2019] Samsung Bioepis: Ontruzant - HER2-positive breast cancer treatment by Lee Han-soo 2019-05-17 16:19
GC MS to supply glycated hemoglobin monitoring system to Japan by Lee Han-soo 2019-05-17 14:37
Saxenda's sales surge 3,000 times yoy in Q1 by Lee Han-soo 2019-05-17 14:37
[Pre-ASCO 2019] Yuhan: Lazertinib -- non-small cell lung cancer treatment by Lee Han-soo 2019-05-17 09:57
여백
여백
여백
Back to Top